ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,558Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 45

$841K Total Retail Price of All Prescriptions

Rank: 2 out of 45

653 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 653 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

5% of this provider’s 653 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 11,109 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
METOPROLOL TARTRATE 643 585 1 12
FUROSEMIDE 577 572 2 6
LABETALOL HCL 457 445 10 3 39
METOPROLOL SUCCINATE 384 369 4 2
ATORVASTATIN CALCIUM 373 372 5 3
ALLOPURINOL 320 317 6 30
WARFARIN SODIUM 289 277 7 4
SIMVASTATIN 276 273 8 9
LISINOPRIL 269 258 9 5
CLOPIDOGREL 266 253 10 11
POTASSIUM CHLORIDE 256 256 11 18
CARVEDILOL 252 236 12 1
PRAVASTATIN SODIUM 249 235 13 22
PLAVIX 234 219 14 13
CRESTOR 234 227 14 19
METFORMIN HCL 208 197 16 32
LOVASTATIN 197 192 17 16
AMLODIPINE BESYLATE 186 181 18 8
DIGOXIN 184 180 19 10
LOSARTAN POTASSIUM 175 167 20 7
ISOSORBIDE MONONITRATE ER 160 160 21 23
NITROSTAT 154 116 22 21
LEVOTHYROXINE SODIUM 151 151 23 41
RANEXA 134 103 24 20
NIFEDIPINE ER 126 116 25 40
HYDROCHLOROTHIAZIDE 116 108 26 17
OMEPRAZOLE 116 108 26 38
AZITHROMYCIN 113 112 28 75
AMIODARONE HCL 107 93 29 24
VYTORIN 104 102 30 79
PRADAXA 102 102 31 14
COUMADIN 99 98 32 36
TAMSULOSIN HCL 95 94 33 54
PANTOPRAZOLE SODIUM 92 80 34 44
GLYBURIDE-METFORMIN HCL 87 83 R 35 83
HYDRALAZINE HCL 85 85 36 59
LEVEMIR FLEXPEN 77 77 37 88
BYSTOLIC 74 70 38 29
DILTIAZEM 24HR ER 73 73 39 31
NAMENDA 72 72 40 90
JANUVIA 71 71 41 91
METOLAZONE 66 66 42 94
DIOVAN 64 64 43 35
LOSARTAN-HYDROCHLOROTHIAZIDE 62 62 44 27
TERAZOSIN HCL 59 59 45 101
EXFORGE 59 59 45 61
ZOLPIDEM TARTRATE 58 58 47 74
DIOVAN HCT 52 52 48 75
TRICOR 52 52 48 106
ACETAMINOPHEN-CODEINE 51 45 S3 50 107
FENOFIBRATE 51 51 50 57
AZOR 51 50 50 107
DONEPEZIL HCL 51 51 50 70
LIPITOR 50 50 54 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.